A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

A groundbreaking study has revealed that a simple at-home saliva test can more accurately detect aggressive prostate cancer ...

The issuer is solely responsible for the content of this announcement.

With an arsenal of antibody assets based on IgE, IgA, and IgG, the newly combined company has opportunities across cancer indications.

Promising results of a study on an at-home saliva test could 'turn the tide on prostate cancer', say experts. Read more.

WITH an impressive attendance of 20,522 participants from 131 countries, the European Congress of Radiology (ECR) 2025 was an ...

U.K. scientists developed a saliva-based test which better predicts the risk of prostate cancer than current prostate-specific antigen (PSA) blood tests by analyzing DNA to look for genetic variants ...

Senti Biosciences, Inc.’s SNTI share price has dipped by 7.34%, which has investors questioning if this is right time to buy.

Assessing prostate-specific antigen levels for 3 months after radical prostatectomy may help minimize overtreatment, ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...